Fairooz Kabbinavar - Jan 30, 2023 Form 3 Insider Report for Cardiff Oncology, Inc. (CRDF)

Role
Chief Medical Officer
Signature
/s/ Fairooz Kabbinavar
Stock symbol
CRDF
Transactions as of
Jan 30, 2023
Transactions value $
$0
Form type
3
Date filed
2/9/2023, 03:50 PM
Next filing
Mar 7, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CRDF Stock Options Jan 30, 2023 Common Stock 425K $1.75 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option will vest on January 30, 2024 and the remaining shares vest in 36 equal monthly installments thereafter, subject to Dr. Kabbinavar's continued service.